🇺🇸 GKOS — Glaukos Corporation

Salud Compra fuerte
← Volver

Precio actual

246,70 USD

Máx. histórico

246,70

0 días

Caída desde máximo

En máximo

Rango 52 semanas

80,91 – 255,19

Variación hoy

+5,86%

Cierre anterior

233,04

Rango de hoy

235,95 – 255,19

Volumen hoy

2.074.592

Peor caída histórica

-69,57%

01/08/2019 → 20/03/2020

Recuperado en 299 días

Volatilidad anualizada ⓘ

54,28%

Información
Nombre completo
Glaukos Corporation
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Medical Devices
Empleados
1.094
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
242,46 USD (puede no estar actualizado)
Primera cotización
25/06/2015
Precio actualizado
hace 1 hora
Sobre la empresa

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor. The company also provides iStent infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. In addition, the company develops iLink, a device used for the treatment of keratoconus without the removal of the epithelium; ILution, a platform of cream-based drug formulation applied to the outer surface of the eyelid for drop less transdermal delivery of pharmaceutically active compounds for the treatment of anterior segment eye disorders; and retinal XR platform to treat age-related macular degeneration, diabetic macular edema, retinal vein occlusion, and other posterior segment retinal diseases. It sells its products to ambulatory surgery centers, hospitals, and physician private practices through a direct sales organization, direct sales subsidiaries, and distributors. The company was formerly known as Transdx, Inc. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
25/08/2017 36,32 36,37 35,13 35,25 -2,46% 3,41% 283.000
24/08/2017 35,85 36,69 35,84 36,14 +1,09% 2,37% 315.800
23/08/2017 37,65 37,87 35,48 35,75 -5,52% 6,35% 693.400
22/08/2017 37,23 38,14 37,11 37,84 +1,94% 2,75% 498.500
21/08/2017 37,56 37,67 36,66 37,12 -0,88% 2,69% 245.500
18/08/2017 37,41 37,91 36,83 37,45 -0,37% 2,90% 333.200
17/08/2017 37,67 38,36 37,50 37,59 -0,58% 2,28% 547.800
16/08/2017 37,92 38,28 37,54 37,81 -0,42% 1,95% 352.100
15/08/2017 37,76 38,84 37,24 37,97 +1,15% 4,24% 352.600
14/08/2017 37,87 38,07 37,17 37,54 +0,11% 2,38% 254.300
11/08/2017 36,02 37,55 35,81 37,50 +3,28% 4,83% 267.500
10/08/2017 36,47 36,88 35,92 36,31 -1,12% 2,63% 409.300
09/08/2017 38,25 38,42 36,69 36,72 -4,72% 4,52% 353.000
08/08/2017 37,21 38,96 37,00 38,54 +2,99% 5,27% 380.200
07/08/2017 36,05 37,50 36,00 37,42 +3,20% 4,16% 435.900
04/08/2017 37,00 37,34 35,56 36,26 -1,36% 4,82% 1.014.300
03/08/2017 37,30 38,60 33,80 36,76 -7,48% 12,87% 3.147.500
02/08/2017 39,36 40,21 39,05 39,73 +0,89% 2,95% 997.500
01/08/2017 40,57 40,68 39,26 39,38 -1,99% 3,50% 350.300
31/07/2017 41,16 41,16 39,40 40,18 -2,26% 4,28% 450.800
28/07/2017 40,84 41,58 40,48 41,11 +0,07% 2,69% 356.600
27/07/2017 42,54 42,57 40,80 41,08 -3,57% 4,16% 305.100
26/07/2017 42,23 42,82 41,95 42,60 +0,76% 2,06% 374.500
25/07/2017 41,32 42,43 41,09 42,28 +2,35% 3,24% 363.000
24/07/2017 40,30 41,35 39,95 41,31 +2,43% 3,47% 240.400
21/07/2017 40,86 40,91 39,91 40,33 -0,84% 2,45% 365.300
20/07/2017 40,88 41,12 40,60 40,67 -0,34% 1,27% 246.900
19/07/2017 41,23 41,68 40,63 40,81 -1,04% 2,55% 403.500
18/07/2017 40,11 41,65 40,01 41,24 +2,79% 4,09% 543.800
17/07/2017 39,93 40,66 39,50 40,12 +0,85% 2,91% 531.500